Press Release

Press Release | Jun 11, 2019

Colorescience®, leading dermatologist-recommended skincare and cosmetics company, is proud to announce that the United States Patent and Trademark Office has issued a patent covering formulations for treating, protecting and repairing skin around the eye area. These patents support Colorescience’s multifaceted formulation and product delivery method of Total Eye® Concentrate and Total Eye® 3-in-1 Renewal Therapy

Press Release | Jun 04, 2019

Colorescience® announces the published results of their study “Beyond sun protection factor: An approach to environmental protection with novel mineral coatings in a vehicle containing a blend of skincare ingredients” in The Journal of Cosmetic Dermatology, that assessed the efficacy of their proprietary EnviroScreen™ technology – a novel, patented formulation that fights against both sun

Press Release | May 23, 2019

Kelly Williams, Founding Chair and co-CEO of PEWIN said of the awards, “PEWIN is so pleased to recognize Luminate Capital, 1315 Capital, the Teacher Retirement System of Texas and The Riverside Company, each of whom are leading by example in their support, promotion and amplification of the outstanding women investors who exist in the private

Press Release | May 17, 2019

Greenbrook TMS Inc. (TSX:GTMS) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today that it has completed its previously announced bought deal public offering and concurrent private placement (the “Offerings”) for total gross proceeds of C$30,579,250. The Offerings were both completed on a bought deal

Press Release | May 02, 2019

Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, announced today that it has entered into a definitive agreement with Solsys Medical, LLC (“Solsys”), a privately held regenerative medical company, to acquire Solsys in an all-stock transaction valued at approximately $97 million. Under the terms of

Press Release | Apr 08, 2019

Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries, announced today it has provided a $20 million venture loan facility to Encore Dermatology, Inc. (“Encore”), of

Press Release | Apr 02, 2019

Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%, as well as rights to market and distribute TRIANEX® 0.05% (Triamcinolone Acetonide Ointment, USP) and PROMISEB® Topical Cream in the United States from Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY), through its wholly owned subsidiary Promius

Press Release | Apr 02, 2019

Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”), through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05% and assignment of its rights to market and distribute, PROMISEB® Topical Cream and TRIANEX® 0.05%

Press Release | Feb 26, 2019

The Private Equity Women Investor Network (PEWIN), the pre-eminent organization for senior-level women investment professionals in private equity, today announced that its Members – Adele Oliva (1315 Capital), Hollie Haynes (Luminate Capital Partners), Kristina Heinze (ParkerGale) and Kate Mitchell (Scale Venture Partners) – have each successfully closed a new fund.

Pages 1 7 8 9 10 11 12 13 14